Psychotic symptoms following sildenafil and panax ginseng treatment in a pramipexole induced manic patient with Parkinson's Disease: a case report Objective: Parkinson's disease (PD) is a chronic neurodegenerative disease characterized by movement abnormalities. It is well known that dopamine agonists are associated with several psychiatric symptoms during the treatment of PD. Pramipexole with a great affinity for D3 receptors, particularly on mesolimbic regions may induce manic or psychotic symptoms by stimulating mesolimbic dopaminergic neurons, as well as the other dopaminergic agonists. Panax Ginseng is a herbal drug which also contains sildenafil and acts through central cholinergic and dopaminergic mechanisms. Sildenafil is a widely used drug for the treatment of erectile dysfunction and predominantly inhibits the breakdown of PDE5 and thus increases the amount of cGMP. Comorbid psychiatric symptoms should be taken into consideration when different classes of drugs were used during the treatment of PD. Methods: We here report on a male patient who first developed mania while receiving pramipexole, and some additional pscyhotic symptoms further emerged when panax ginseng and sildenafil were added to the ongoing pramipexole treatment because of erectile dysfunctions. Results: A patient with PD was admitted to psychiatry unit with some psychotic symptoms after taking sildenafil and panax ginseng for erectile dysfunction in combination with pramipexole. Conclusion: This case demonstrated that some drugs which were not primarily used in the treatment of PD, might have caused some severe psychotic symptoms due to underlying pschopathology of PD, drug interaction, and the action of mechanisms of the dopaminergic drugs. (7-9). Sildenafil is a widely used drug for the treatment of erectile dysfunction and predominantly inhibits the breakdown of PDE5 and thus increases the amount of cGMP (10) . Previously, it was reported that sildenafil induced a relapse in a case of bipolar disorder (11) . Panax Ginseng is a herbal drug which acts through central cholinergic and dopaminergic mechanisms (12) . In Turkey, Ministry of Food, Agriculture and Livestock announced that some ginseng products violating Turkish food codex contained sildenafil (13) . To date a few cases of mania and psychosis were reported due to the use of ginseng (14, 15) .We here present a male patient who developed some psychotic symptoms when sildenafil and panax ginseng were added to the ongoing pramipexole treatment in a patients with PD. To our knowledge, this is the first case with PD who developed psychotic symptoms following a consecutive use of sildenafil and panax ginseng in combination with pramipexole.
CASE REPORT
Mr. D was a 57-year-old, married male who was admitted in the psychiatric ward with aggressive behaviors against his wife because of his delusions of jealousy. He had a 3-years history of PD and had received pramipexole 1.5 mg/day, rasagiline mesylate 1 mg/day and amantadin sulfate 200 mg/day within last year. Following the dose of pramipexole was increased to 3 mg/day, it was reported that some manic symptoms such as euphoria, spending too much money, insomnia, being more talkative, hypersexuality, and hyperactivity emerged. Concurrently, the patient had been started 50 mg/day of sildenafil for his erectile dysfunction which occurred after an inguinal hernia operation. Two 
DISCUSSION
Pramipexole has a great affinity for D3 receptors, particularly on mesolimbic regions and therefore may induce manic or psychotic symptoms by stimulating mesolimbic dopaminergic neurons, as well as the other dopaminergic agonists (1, 9, (16) (17) (18) (19) . Previously, it was reported that sildenafil induced a relapse in a case of bipolar disorder. Baggott and Singh (11) have suggested that PDE inhibition might lead to an excess of NO-stimulated cGMP and therefore induced a relapse in bipolar disorder. In the central nervous system, NO serves as a major messenger molecule regulating noradrenaline and dopamine release. In studies on the function of NO in mood disorders, schizophrenia, autism, obsessive compulsive disorder, and Alzheimer's disease, several quantitative changes in the NO production have been found (20) (21) (22) . Sildenafil, may suppress NO activity by inhibiting NOS in CNS as well as the other antidepressants.
Therefore, the activity of glutamate is inhibited, and this action of mechanism is supposed to partially explain the effects of several antidepressants and sildenafil (23, 24) .
Several studies have found that acute administration of sildenafil has anxiogenic effects in rodents (25, 26) . In contrast, chronic use of sildenafil in rats is associated with an anxiolytic action in rats (27) . In our case, the early occurrence of psychotic symptoms might be related to the acute effects of sildenafil. In addition, since sildenafil crosses blood-brain barrier (28) , it might have caused increased the effects of previous drugs. Hence, we considered that paranoid symptoms and hostile behaviors emerged just after sildenafil and panax ginseng were administrated. Also, the pramipexole-induced manic symptoms were worsened by addition of sildenafil, and panax ginseng. Therefore, our case might demonstrate that sildenafil and panax ginseng might have worsened previous manic symptoms and caused some additional psychotic symptoms.
CONCLUSIONS
Our case might demonstrate that the emergence of psychotic and manic symptoms might seem to be strongly correlated with the concomitant use of pramipexole, panax ginseng, and sildenafil. We suggested that increasing the dose of pramipexole caused manic symptoms and concurrent use of panax ginseng, and sildenafil worsened the manic symptoms and also caused significant paranoid symptoms. We considered that panax ginseng and sildenafil might have caused manic and paranoid symptoms by changing the activities of NO and glutamatergic systems. In future research, the role of NO via sildenafil containing drugs should be evaluated carefully in psychiatric disorders, such as bipolar disorder and psychosis. Any drugs containing sildenafil should be carefully administrated in patients with a dopaminergic abnormality such as PD. The clinicians should be careful in using sildenafil containing drugs in addition to several dopaminergic drugs.
